 | • レポートコード：D0804-06990 • 出版社/出版日：GlobalInfoResearch / 2020年7月28日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール • 産業分類：医薬品・治療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、内分泌療法薬（ETD）の世界市場を広く調査・分析し、今後の市場展望をまとめております。内分泌療法薬（ETD）の種類別市場規模（糖尿病治療薬、骨粗しょう症治療薬、避妊薬、その他）、用途別市場規模（糖尿病治療、骨粗しょう症治療、避妊、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Novo Nordisk、Bayer、Sanofi、AstraZeneca、Huadong Medicine、Generex Biotechnology、Pfizer、MSD、Tonghua Dongbao Pharmaceutical ・地域別グローバル市場分析 2015年-2020年 ・内分泌療法薬（ETD）の北米市場（アメリカ、カナダ、メキシコ） ・内分泌療法薬（ETD）のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・内分泌療法薬（ETD）のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・内分泌療法薬（ETD）の南米市場（ブラジル、アルゼンチン） ・内分泌療法薬（ETD）の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：糖尿病治療薬、骨粗しょう症治療薬、避妊薬、その他 ・用途別分析：糖尿病治療、骨粗しょう症治療、避妊、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The Endocrine Therapy Drugs (ETDs) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Endocrine Therapy Drugs (ETDs) sales will be xx in 2020 from Endocrine Therapy Drugs (ETDs) million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Endocrine Therapy Drugs (ETDs) market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Endocrine Therapy Drugs (ETDs) industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Endocrine Therapy Drugs (ETDs) and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Endocrine Therapy Drugs (ETDs) market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Endocrine Therapy Drugs (ETDs) market has been segmented into
Antidiabetic Drugs
Anti-osteoporosis Drugs
Contraceptive
Other
By Application, Endocrine Therapy Drugs (ETDs) has been segmented into:
Diabetes Treatment
Osteoporosis Treatment
Contraception
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Endocrine Therapy Drugs (ETDs) market presented in the report. This section sheds light on the sales growth of different regional and country-level Endocrine Therapy Drugs (ETDs) markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Endocrine Therapy Drugs (ETDs) market.
The report offers in-depth assessment of the growth and other aspects of the Endocrine Therapy Drugs (ETDs) market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Endocrine Therapy Drugs (ETDs) Market Share Analysis
Endocrine Therapy Drugs (ETDs) competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Endocrine Therapy Drugs (ETDs) sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Endocrine Therapy Drugs (ETDs) sales, revenue and market share for each player covered in this report.
The major players covered in Endocrine Therapy Drugs (ETDs) are:
Novo Nordisk
Bayer
Sanofi
AstraZeneca
Huadong Medicine
Generex Biotechnology
Pfizer
MSD
Tonghua Dongbao Pharmaceutical
Among other players domestic and global, Endocrine Therapy Drugs (ETDs) market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Endocrine Therapy Drugs (ETDs) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Endocrine Therapy Drugs (ETDs), with price, sales, revenue and global market share of Endocrine Therapy Drugs (ETDs) in 2018 and 2019.
Chapter 3, the Endocrine Therapy Drugs (ETDs) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Endocrine Therapy Drugs (ETDs) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Endocrine Therapy Drugs (ETDs) market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Endocrine Therapy Drugs (ETDs) sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Endocrine Therapy Drugs (ETDs) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Endocrine Therapy Drugs (ETDs) Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Antidiabetic Drugs
1.2.3 Anti-osteoporosis Drugs
1.2.4 Contraceptive
1.2.5 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Endocrine Therapy Drugs (ETDs) Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Diabetes Treatment
1.3.3 Osteoporosis Treatment
1.3.4 Contraception
1.3.5 Other
1.4 Overview of Global Endocrine Therapy Drugs (ETDs) Market
1.4.1 Global Endocrine Therapy Drugs (ETDs) Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
1.6 COVID-19 Outbreak: Endocrine Therapy Drugs (ETDs) Industry Impact
1.6.1 COVID-19 Potential Implications for the Endocrine Therapy Drugs (ETDs)
1.6.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Endocrine Therapy Drugs (ETDs)
1.6.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.6.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.6.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.6.2 Opportunity Analysis in Covid-19 Crisis
1.6.3 Market Risk and Restraints
1.6.4 Market Driving Force
2 Manufacturers Profiles
2.1 Novo Nordisk
2.1.1 Novo Nordisk Details
2.1.2 Novo Nordisk Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Novo Nordisk SWOT Analysis
2.1.4 Novo Nordisk Product and Services
2.1.5 Novo Nordisk Endocrine Therapy Drugs (ETDs) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Bayer
2.2.1 Bayer Details
2.2.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Bayer SWOT Analysis
2.2.4 Bayer Product and Services
2.2.5 Bayer Endocrine Therapy Drugs (ETDs) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Sanofi SWOT Analysis
2.3.4 Sanofi Product and Services
2.3.5 Sanofi Endocrine Therapy Drugs (ETDs) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 AstraZeneca
2.4.1 AstraZeneca Details
2.4.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 AstraZeneca SWOT Analysis
2.4.4 AstraZeneca Product and Services
2.4.5 AstraZeneca Endocrine Therapy Drugs (ETDs) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Huadong Medicine
2.5.1 Huadong Medicine Details
2.5.2 Huadong Medicine Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Huadong Medicine SWOT Analysis
2.5.4 Huadong Medicine Product and Services
2.5.5 Huadong Medicine Endocrine Therapy Drugs (ETDs) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Generex Biotechnology
2.6.1 Generex Biotechnology Details
2.6.2 Generex Biotechnology Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Generex Biotechnology SWOT Analysis
2.6.4 Generex Biotechnology Product and Services
2.6.5 Generex Biotechnology Endocrine Therapy Drugs (ETDs) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Pfizer
2.7.1 Pfizer Details
2.7.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Pfizer SWOT Analysis
2.7.4 Pfizer Product and Services
2.7.5 Pfizer Endocrine Therapy Drugs (ETDs) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 MSD
2.8.1 MSD Details
2.8.2 MSD Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 MSD SWOT Analysis
2.8.4 MSD Product and Services
2.8.5 MSD Endocrine Therapy Drugs (ETDs) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Tonghua Dongbao Pharmaceutical
2.9.1 Tonghua Dongbao Pharmaceutical Details
2.9.2 Tonghua Dongbao Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Tonghua Dongbao Pharmaceutical SWOT Analysis
2.9.4 Tonghua Dongbao Pharmaceutical Product and Services
2.9.5 Tonghua Dongbao Pharmaceutical Endocrine Therapy Drugs (ETDs) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Endocrine Therapy Drugs (ETDs) Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Endocrine Therapy Drugs (ETDs) Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Endocrine Therapy Drugs (ETDs) Manufacturer Market Share in 2019
3.3.2 Top 6 Endocrine Therapy Drugs (ETDs) Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Endocrine Therapy Drugs (ETDs) Sales, Revenue and Market Share by Regions
4.1.1 Global Endocrine Therapy Drugs (ETDs) Sales and Market Share by Regions (2015-2020)
4.1.2 Global Endocrine Therapy Drugs (ETDs) Revenue and Market Share by Regions (2015-2020)
4.2 North America Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2015-2020)
4.3 Europe Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2015-2020)
4.5 South America Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Endocrine Therapy Drugs (ETDs) Sales, Revenue and Market Share by Country
5.1.1 North America Endocrine Therapy Drugs (ETDs) Sales and Market Share by Country (2015-2020)
5.1.2 North America Endocrine Therapy Drugs (ETDs) Revenue and Market Share by Country (2015-2020)
5.2 United States Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2015-2020)
5.3 Canada Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2015-2020)
5.4 Mexico Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Endocrine Therapy Drugs (ETDs) Sales, Revenue and Market Share by Country
6.1.1 Europe Endocrine Therapy Drugs (ETDs) Sales and Market Share by Country (2015-2020)
6.1.2 Europe Endocrine Therapy Drugs (ETDs) Revenue and Market Share by Country (2015-2020)
6.2 Germany Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2015-2020)
6.3 UK Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2015-2020)
6.4 France Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2015-2020)
6.5 Russia Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2015-2020)
6.6 Italy Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Endocrine Therapy Drugs (ETDs) Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Endocrine Therapy Drugs (ETDs) Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Endocrine Therapy Drugs (ETDs) Revenue and Market Share by Regions (2015-2020)
7.2 China Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2015-2020)
7.3 Japan Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2015-2020)
7.4 Korea Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2015-2020)
7.5 India Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2015-2020)
7.7 Australia Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Endocrine Therapy Drugs (ETDs) Sales, Revenue and Market Share by Country
8.1.1 South America Endocrine Therapy Drugs (ETDs) Sales and Market Share by Country (2015-2020)
8.1.2 South America Endocrine Therapy Drugs (ETDs) Revenue and Market Share by Country (2015-2020)
8.2 Brazil Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2015-2020)
8.3 Argentina Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Endocrine Therapy Drugs (ETDs) Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Endocrine Therapy Drugs (ETDs) Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Endocrine Therapy Drugs (ETDs) Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2015-2020)
9.3 Turkey Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2015-2020)
9.4 Egypt Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2015-2020)
9.5 South Africa Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Endocrine Therapy Drugs (ETDs) Sales and Market Share by Type (2015-2020)
10.2 Global Endocrine Therapy Drugs (ETDs) Revenue and Market Share by Type (2015-2020)
10.3 Global Endocrine Therapy Drugs (ETDs) Price by Type (2015-2020)
11 Global Endocrine Therapy Drugs (ETDs) Market Segment by Application
11.1 Global Endocrine Therapy Drugs (ETDs) Sales Market Share by Application (2015-2020)
11.2 Global Endocrine Therapy Drugs (ETDs) Revenue Market Share by Application (2015-2020)
11.3 Global Endocrine Therapy Drugs (ETDs) Price by Application (2015-2020)
12 Market Forecast
12.1 Global Endocrine Therapy Drugs (ETDs) Sales, Revenue and Growth Rate (2021-2025)
12.2 Endocrine Therapy Drugs (ETDs) Market Forecast by Regions (2021-2025)
12.2.1 North America Endocrine Therapy Drugs (ETDs) Market Forecast (2021-2025)
12.2.2 Europe Endocrine Therapy Drugs (ETDs) Market Forecast (2021-2025)
12.2.3 Asia-Pacific Endocrine Therapy Drugs (ETDs) Market Forecast (2021-2025)
12.2.4 South America Endocrine Therapy Drugs (ETDs) Market Forecast (2021-2025)
12.2.5 Middle East & Africa Endocrine Therapy Drugs (ETDs) Market Forecast (2021-2025)
12.3 Endocrine Therapy Drugs (ETDs) Market Forecast by Type (2021-2025)
12.3.1 Global Endocrine Therapy Drugs (ETDs) Sales Forecast by Type (2021-2025)
12.3.2 Global Endocrine Therapy Drugs (ETDs) Market Share Forecast by Type (2021-2025)
12.4 Endocrine Therapy Drugs (ETDs) Market Forecast by Application (2021-2025)
12.4.1 Global Endocrine Therapy Drugs (ETDs) Sales Forecast by Application (2021-2025)
12.4.2 Global Endocrine Therapy Drugs (ETDs) Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Endocrine Therapy Drugs (ETDs) Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Endocrine Therapy Drugs (ETDs) by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Endocrine Therapy Drugs (ETDs) Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Endocrine Therapy Drugs (ETDs) Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 9. Novo Nordisk Endocrine Therapy Drugs (ETDs) Major Business
Table 10. Novo Nordisk Endocrine Therapy Drugs (ETDs) Total Revenue (USD Million) (2018-2019)
Table 11. Novo Nordisk SWOT Analysis
Table 12. Novo Nordisk Endocrine Therapy Drugs (ETDs) Product and Services
Table 13. Novo Nordisk Endocrine Therapy Drugs (ETDs) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Bayer Basic Information, Manufacturing Base and Competitors
Table 15. Bayer Endocrine Therapy Drugs (ETDs) Major Business
Table 16. Bayer Endocrine Therapy Drugs (ETDs) Total Revenue (USD Million) (2018-2019)
Table 17. Bayer SWOT Analysis
Table 18. Bayer Endocrine Therapy Drugs (ETDs) Product and Services
Table 19. Bayer Endocrine Therapy Drugs (ETDs) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Sanofi Basic Information, Manufacturing Base and Competitors
Table 21. Sanofi Endocrine Therapy Drugs (ETDs) Major Business
Table 22. Sanofi Endocrine Therapy Drugs (ETDs) Total Revenue (USD Million) (2018-2019)
Table 23. Sanofi SWOT Analysis
Table 24. Sanofi Endocrine Therapy Drugs (ETDs) Product and Services
Table 25. Sanofi Endocrine Therapy Drugs (ETDs) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 27. AstraZeneca Endocrine Therapy Drugs (ETDs) Major Business
Table 28. AstraZeneca Endocrine Therapy Drugs (ETDs) Total Revenue (USD Million) (2018-2019)
Table 29. AstraZeneca SWOT Analysis
Table 30. AstraZeneca Endocrine Therapy Drugs (ETDs) Product and Services
Table 31. AstraZeneca Endocrine Therapy Drugs (ETDs) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Huadong Medicine Basic Information, Manufacturing Base and Competitors
Table 33. Huadong Medicine Endocrine Therapy Drugs (ETDs) Major Business
Table 34. Huadong Medicine Endocrine Therapy Drugs (ETDs) Total Revenue (USD Million) (2018-2019)
Table 35. Huadong Medicine SWOT Analysis
Table 36. Huadong Medicine Endocrine Therapy Drugs (ETDs) Product and Services
Table 37. Huadong Medicine Endocrine Therapy Drugs (ETDs) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Generex Biotechnology Basic Information, Manufacturing Base and Competitors
Table 39. Generex Biotechnology Endocrine Therapy Drugs (ETDs) Major Business
Table 40. Generex Biotechnology Endocrine Therapy Drugs (ETDs) Total Revenue (USD Million) (2018-2019)
Table 41. Generex Biotechnology SWOT Analysis
Table 42. Generex Biotechnology Endocrine Therapy Drugs (ETDs) Product and Services
Table 43. Generex Biotechnology Endocrine Therapy Drugs (ETDs) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Pfizer Basic Information, Manufacturing Base and Competitors
Table 45. Pfizer Endocrine Therapy Drugs (ETDs) Major Business
Table 46. Pfizer Endocrine Therapy Drugs (ETDs) Total Revenue (USD Million) (2018-2019)
Table 47. Pfizer SWOT Analysis
Table 48. Pfizer Endocrine Therapy Drugs (ETDs) Product and Services
Table 49. Pfizer Endocrine Therapy Drugs (ETDs) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. MSD Basic Information, Manufacturing Base and Competitors
Table 51. MSD Endocrine Therapy Drugs (ETDs) Major Business
Table 52. MSD Endocrine Therapy Drugs (ETDs) Total Revenue (USD Million) (2018-2019)
Table 53. MSD SWOT Analysis
Table 54. MSD Endocrine Therapy Drugs (ETDs) Product and Services
Table 55. MSD Endocrine Therapy Drugs (ETDs) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. Tonghua Dongbao Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 57. Tonghua Dongbao Pharmaceutical Endocrine Therapy Drugs (ETDs) Major Business
Table 58. Tonghua Dongbao Pharmaceutical Endocrine Therapy Drugs (ETDs) Total Revenue (USD Million) (2018-2019)
Table 59. Tonghua Dongbao Pharmaceutical SWOT Analysis
Table 60. Tonghua Dongbao Pharmaceutical Endocrine Therapy Drugs (ETDs) Product and Services
Table 61. Tonghua Dongbao Pharmaceutical Endocrine Therapy Drugs (ETDs) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 62. Global Endocrine Therapy Drugs (ETDs) Sales by Manufacturer (2018-2019) (Kiloton)
Table 63. Global Endocrine Therapy Drugs (ETDs) Revenue by Manufacturer (2018-2019) (USD Million)
Table 64. Global Endocrine Therapy Drugs (ETDs) Sales by Regions (2015-2020) (Kiloton)
Table 65. Global Endocrine Therapy Drugs (ETDs) Sales Market Share by Regions (2015-2020)
Table 66. Global Endocrine Therapy Drugs (ETDs) Revenue by Regions (2015-2020) (USD Million)
Table 67. North America Endocrine Therapy Drugs (ETDs) Sales by Countries (2015-2020) (Kiloton)
Table 68. North America Endocrine Therapy Drugs (ETDs) Sales Market Share by Countries (2015-2020)
Table 69. North America Endocrine Therapy Drugs (ETDs) Revenue by Countries (2015-2020) (USD Million)
Table 70. North America Endocrine Therapy Drugs (ETDs) Revenue Market Share by Countries (2015-2020)
Table 71. Europe Endocrine Therapy Drugs (ETDs) Sales by Countries (2015-2020) (Kiloton)
Table 72. Europe Endocrine Therapy Drugs (ETDs) Sales Market Share by Countries (2015-2020)
Table 73. Europe Endocrine Therapy Drugs (ETDs) Revenue by Countries (2015-2020) (USD Million)
Table 74. Asia-Pacific Endocrine Therapy Drugs (ETDs) Sales by Regions (2015-2020) (Kiloton)
Table 75. Asia-Pacific Endocrine Therapy Drugs (ETDs) Sales Market Share by Regions (2015-2020)
Table 76. Asia-Pacific Endocrine Therapy Drugs (ETDs) Revenue by Regions (2015-2020) (USD Million)
Table 77. South America Endocrine Therapy Drugs (ETDs) Sales by Countries (2015-2020) (Kiloton)
Table 78. South America Endocrine Therapy Drugs (ETDs) Sales Market Share by Countries (2015-2020)
Table 79. South America Endocrine Therapy Drugs (ETDs) Revenue by Countries (2015-2020) (USD Million)
Table 80. South America Endocrine Therapy Drugs (ETDs) Revenue Market Share by Countries (2015-2020)
Table 81. Middle East & Africa Endocrine Therapy Drugs (ETDs) Sales by Countries (2015-2020) (Kiloton)
Table 82. Middle East & Africa Endocrine Therapy Drugs (ETDs) Sales Market Share by Countries (2015-2020)
Table 83. Middle East & Africa Endocrine Therapy Drugs (ETDs) Revenue by Countries (2015-2020) (USD Million)
Table 84. Middle East & Africa Endocrine Therapy Drugs (ETDs) Revenue Market Share by Countries (2015-2020)
Table 85. Global Endocrine Therapy Drugs (ETDs) Sales by Type (2015-2020) (Kiloton)
Table 86. Global Endocrine Therapy Drugs (ETDs) Sales Share by Type (2015-2020)
Table 87. Global Endocrine Therapy Drugs (ETDs) Revenue by Type (2015-2020) (USD Million)
Table 88. Global Endocrine Therapy Drugs (ETDs) Revenue Share by Type (2015-2020)
Table 89. Global Endocrine Therapy Drugs (ETDs) Sales by Application (2015-2020) (Kiloton)
Table 90. Global Endocrine Therapy Drugs (ETDs) Sales Share by Application (2015-2020)
Table 91. Global Endocrine Therapy Drugs (ETDs) Sales Forecast by Regions (2021-2025) (Kiloton)
Table 92. Global Endocrine Therapy Drugs (ETDs) Market Share Forecast by Regions (2021-2025)
Table 93. Global Endocrine Therapy Drugs (ETDs) Sales Forecast by Type (2021-2025) (Kiloton)
Table 94. Global Endocrine Therapy Drugs (ETDs) Market Share Forecast by Type (2021-2025)
Table 95. Global Endocrine Therapy Drugs (ETDs) Sales Forecast by Application (2021-2025)
Table 96. Global Endocrine Therapy Drugs (ETDs) Market Share Forecast by Application (2021-2025)
Table 97. Direct Channel Pros & Cons
Table 98. Indirect Channel Pros & Cons
Table 99. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Endocrine Therapy Drugs (ETDs) Picture
Figure 2. Global Sales Market Share of Endocrine Therapy Drugs (ETDs) by Type in 2019
Figure 3. Antidiabetic Drugs Picture
Figure 4. Anti-osteoporosis Drugs Picture
Figure 5. Contraceptive Picture
Figure 6. Other Picture
Figure 7. Endocrine Therapy Drugs (ETDs) Sales Market Share by Application in 2018
Figure 8. Diabetes Treatment Picture
Figure 9. Osteoporosis Treatment Picture
Figure 10. Contraception Picture
Figure 11. Other Picture
Figure 12. Global Endocrine Therapy Drugs (ETDs) Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States Endocrine Therapy Drugs (ETDs) Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada Endocrine Therapy Drugs (ETDs) Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico Endocrine Therapy Drugs (ETDs) Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany Endocrine Therapy Drugs (ETDs) Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France Endocrine Therapy Drugs (ETDs) Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK Endocrine Therapy Drugs (ETDs) Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia Endocrine Therapy Drugs (ETDs) Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy Endocrine Therapy Drugs (ETDs) Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China Endocrine Therapy Drugs (ETDs) Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan Endocrine Therapy Drugs (ETDs) Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea Endocrine Therapy Drugs (ETDs) Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India Endocrine Therapy Drugs (ETDs) Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia Endocrine Therapy Drugs (ETDs) Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia Endocrine Therapy Drugs (ETDs) Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil Endocrine Therapy Drugs (ETDs) Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt Endocrine Therapy Drugs (ETDs) Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia Endocrine Therapy Drugs (ETDs) Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa Endocrine Therapy Drugs (ETDs) Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey Endocrine Therapy Drugs (ETDs) Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global Endocrine Therapy Drugs (ETDs) Sales Market Share by Manufacturer in 2019
Figure 33. Global Endocrine Therapy Drugs (ETDs) Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 Endocrine Therapy Drugs (ETDs) Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 Endocrine Therapy Drugs (ETDs) Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2015-2020) (Kiloton)
Figure 38. Global Endocrine Therapy Drugs (ETDs) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global Endocrine Therapy Drugs (ETDs) Revenue Market Share by Regions (2015-2020)
Figure 40. Global Endocrine Therapy Drugs (ETDs) Revenue Market Share by Regions in 2018
Figure 41. North America Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2015-2020)
Figure 42. Europe Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2015-2020)
Figure 44. South America Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2015-2020)
Figure 46. North America Endocrine Therapy Drugs (ETDs) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America Endocrine Therapy Drugs (ETDs) Sales Market Share by Countries (2015-2020)
Figure 48. North America Endocrine Therapy Drugs (ETDs) Sales Market Share by Countries in 2018
Figure 49. North America Endocrine Therapy Drugs (ETDs) Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America Endocrine Therapy Drugs (ETDs) Revenue Market Share by Countries in 2018
Figure 51. United States Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2015-2020) (Kiloton)
Figure 52. Canada Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2015-2020) (Kiloton)
Figure 53. Mexico Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2015-2020) (Kiloton)
Figure 54. Europe Endocrine Therapy Drugs (ETDs) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe Endocrine Therapy Drugs (ETDs) Revenue Market Share by Countries (2015-2020)
Figure 56. Europe Endocrine Therapy Drugs (ETDs) Revenue Market Share by Countries in 2019
Figure 57. Germany Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2015-2020) (Kiloton)
Figure 58. UK Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2015-2020) (Kiloton)
Figure 59. France Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2015-2020) (Kiloton)
Figure 60. Russia Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2015-2020) (Kiloton)
Figure 61. Italy Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2015-2020) (Kiloton)
Figure 62. Asia-Pacific Endocrine Therapy Drugs (ETDs) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific Endocrine Therapy Drugs (ETDs) Sales Market Share by Regions 2019
Figure 64. Asia-Pacific Endocrine Therapy Drugs (ETDs) Revenue Market Share by Regions 2019
Figure 65. China Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2015-2020) (Kiloton)
Figure 66. Japan Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2015-2020) (Kiloton)
Figure 67. Korea Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2015-2020) (Kiloton)
Figure 68. India Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2015-2020) (Kiloton)
Figure 69. Southeast Asia Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2015-2020) (Kiloton)
Figure 70. South America Endocrine Therapy Drugs (ETDs) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America Endocrine Therapy Drugs (ETDs) Sales Market Share by Countries in 2019
Figure 72. South America Endocrine Therapy Drugs (ETDs) Revenue Market Share by Countries in 2019
Figure 73. Brazil Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2015-2020) (Kiloton)
Figure 74. Argentina Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2015-2020) (Kiloton)
Figure 75. Middle East and Africa Endocrine Therapy Drugs (ETDs) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa Endocrine Therapy Drugs (ETDs) Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa Endocrine Therapy Drugs (ETDs) Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa Endocrine Therapy Drugs (ETDs) Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2015-2020) (Kiloton)
Figure 80. Egypt Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2015-2020) (Kiloton)
Figure 81. Turkey Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2015-2020) (Kiloton)
Figure 82. South Africa Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2015-2020) (Kiloton)
Figure 83. Global Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2021-2025) (Kiloton)
Figure 84. Global Endocrine Therapy Drugs (ETDs) Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales Endocrine Therapy Drugs (ETDs) Market Forecast (2021-2025) (Kiloton)
Figure 86. Europe Sales Endocrine Therapy Drugs (ETDs) Market Forecast (2021-2025) (Kiloton)
Figure 87. Asia-Pacific Sales Endocrine Therapy Drugs (ETDs) Market Forecast (2021-2025) (Kiloton)
Figure 88. South America Sales Endocrine Therapy Drugs (ETDs) Market Forecast (2021-2025) (Kiloton)
Figure 89. Middle East & Africa Sales Endocrine Therapy Drugs (ETDs) Market Forecast (2021-2025) (Kiloton)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
アンチエイジング薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Anti-Ageing Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 7.2% in the forecast period of 2020 to 2025 and will expected to reach USD 106360 million by 2025, from USD 80490 million in 2019. The Anti-Ageing Drugs m…- 抗腫瘍薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Anti-tumor Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade…
- 抗インフルエンザ薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Anti-influenza Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …
- 抗喘息薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Anti Asthma Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.2% in the forecast period of 2020 to 2025 and will expected to reach USD 24300 million by 2025, from USD 21410 million in 2019. The Anti Asthma Drugs ma…
- 抗ウイルス薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Anti-Viral Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Anti-Viral Drugs market repo…